do-me/EUR-LEX huggingface dataset:
Case T-512/23: Action brought on 20 August 2023 — Cellphenomics v EUIPO (CellCompDx)
Date: 2023-08-20
Institutions: General Court
Subjects: EU trade mark, drug surveillance, electronic publishing, industrial chemistry, medical diagnosis, pharmaceutical product, registered trade mark, therapeutics, trade-mark law, veterinary medicinal product








C_202300036EN.000101.fmx.xml












Official Journal of the European Union


EN
Series C













C/2023/36


9.10.2023





Action brought on 20 August 2023 — Cellphenomics v EUIPO (CellCompDx)
(Case T-512/23)
(C/2023/36)
Language of the case: German

Parties


Applicant: Cellphenomics GmbH (Berlin, Germany) (represented by: C. Adori, lawyer)

Defendant: European Union Intellectual Property Office (EUIPO)

Details of the proceedings before EUIPO


Trade mark at issue: Application for the EU word mark CellCompDx — Application No 18 687 445

Contested decision: Decision of the Second Board of Appeal of EUIPO of 23 May 2023 in Case R 2571/2022-2

Form of order sought

The applicant claims that the Court should:






—


annul the contested decision;










—


order EUIPO to alter the decision and to take a new decision on the registration of EU trade mark No 18 687 445, taking into account the findings of the General Court;










—


order EUIPO to pay the costs.





Pleas in law







—


Infringement of Article 7(1)(c) of Regulation (EU) 2017/1001 of the European Parliament and of the Council;










—


Infringement of Article 7(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council.






ELI: http://data.europa.eu/eli/C/2023/36/oj
ISSN 1977-091X (electronic edition)